Shanghai Kehua Bio-engineering (002022.SZ): Two products obtained medical device registration certificates.
Shanghai Kehua Bio-engineering (002022.SZ) announced that recently, the company and its controlling subsidiary Suzhou Tianlong Biotechnology Co., Ltd. (hereinafter referred to as "Suzhou Tianlong") received medical device registration certificates (in vitro diagnostic reagents) issued by the National Medical Products Administration. The products involved are: "Chlamydia trachomatis nucleic acid detection kit (PCR-fluorescence method)" and "Parainfluenza virus nucleic acid detection kit (fluorescence PCR method)".
Shanghai Kehua Bio-engineering (002022.SZ) announced that recently, the company and its controlling subsidiary Suzhou Tianlong Biotechnology Co., Ltd. (hereinafter referred to as "Suzhou Tianlong") received medical device registration certificates (in vitro diagnostic reagents) issued by the National Medical Products Administration. The products involved are: "Chlamydia trachomatis nucleic acid detection kit (PCR-fluorescence method)" and "Parainfluenza virus nucleic acid detection kit (fluorescence PCR method)".
Related Articles
Shenyang Blower Works Group (601091.SH) shares will be listed on the main board of the Shanghai Stock Exchange on September 17.
A-Share Announcement Highlights | Caissa Tourism Group (000796.SZ) Reports to Police! Grandsubsidiary Defrauded of Nearly 27 Million Yuan in Contract Fraud
Lens Technology (06613) plans to contribute RMB 200 million to establish a fund with professional investment institutions.
Shenyang Blower Works Group (601091.SH) shares will be listed on the main board of the Shanghai Stock Exchange on September 17.
A-Share Announcement Highlights | Caissa Tourism Group (000796.SZ) Reports to Police! Grandsubsidiary Defrauded of Nearly 27 Million Yuan in Contract Fraud
Lens Technology (06613) plans to contribute RMB 200 million to establish a fund with professional investment institutions.
RECOMMEND
